tizanidine hydrochloride
Generic: tizanidine hydrochloride
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
tizanidine hydrochloride
Generic Name
tizanidine hydrochloride
Labeler
actavis pharma, inc.
Dosage Form
CAPSULE, GELATIN COATED
Routes
Active Ingredients
tizanidine hydrochloride 2 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0591-2788
Product ID
0591-2788_5c8f8c47-4f62-4954-8135-957c967dd7cb
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA021447
Listing Expiration
2026-12-31
Marketing Start
2012-02-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05912788
Hyphenated Format
0591-2788
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tizanidine hydrochloride (source: ndc)
Generic Name
tizanidine hydrochloride (source: ndc)
Application Number
NDA021447 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
Packaging
- 150 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0591-2788-86)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5c8f8c47-4f62-4954-8135-957c967dd7cb", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["485484", "485485", "485486"], "spl_set_id": ["cb8b01b3-bcec-4762-9d67-0db018ef6b22"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0591-2788-86)", "package_ndc": "0591-2788-86", "marketing_start_date": "20120206"}], "brand_name": "tizanidine hydrochloride", "product_id": "0591-2788_5c8f8c47-4f62-4954-8135-957c967dd7cb", "dosage_form": "CAPSULE, GELATIN COATED", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "0591-2788", "generic_name": "tizanidine hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tizanidine hydrochloride", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "NDA021447", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20120206", "listing_expiration_date": "20261231"}